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Although obestatin appears to be involved in the gut-brain network whereby hormones and substances from the stomach and intestine signal the brain about satiety or hunger (13) , very little is known and controversial results have been reported to date about its physiological role (9, 16) .
Contrasting results have been also reported concerning the effects of obestatin, centrally or peripherally administered, on gastrointestinal motility in rodents (13) .
In this view, the study on fed and fasted motor activities in the stomach and duodenum of freely moving conscious rats suggested that intravenous injection of obestatin inhibits, in the fed state, motor activity in the antrum and duodenum: vagal afferent pathways might be partially involved in the action of obestatin on duodenal motility, as confirmed by the increase of the number of c-Fos-positive neurons in the nucleus of the solitary tract following intravenous injection of obestatin (2) .
At variance, lack of effects of peripheral injection of obestatin on gastric motility or vagal afferent activity has been reported in rats (16) as well as on gastric emptying in ghrelin knockout mice (9) . Intracerebroventricular injection, too, of obestatin failed to influence colonic motility in freely fed, conscious rats (7) .
Few studies are present on the effects of obestatin on "in vitro" gastric preparations. Fundic smooth muscle circular strips from mice and rats did not respond to obestatin either in the absence or in the presence of electrical field stimulation (6, 10) also in ghrelin knockout mice (9) .
Because the above in vitro results have been obtained from the circular layer, the aim of the present study was to investigate, through a combined mechanical and electrophysiological approach, whether obestatin may influence the longitudinal smooth muscle of the mouse gastric fundus. For comparison, we also performed preliminary experiments to test obestatin on the circular layer and examined muscle strips from a separate section of the stomach (i.e., the antrum), that could be relevant in understanding if a differential function exists for obestatin in different gastric regions.
MATERIALS AND METHODS
Animals and mechanical recording. Experiments were carried out on male mice (Harlan, Udine, Italy). The animals were fed standard laboratory chow and water and were housed under a 12:12-h lightdark photoperiod and controlled temperature (21 Ϯ 1°C). The experimental protocol was designed in compliance with the Principles of Laboratory Animal Care (NIH Publications 86 -23, revised 1985) and the recommendations of the European Economic Community (86/609/ CEE) and was approved by the Florence Universities Ethics Committees. The mice were killed by cervical dislocation, the stomach was rapidly dissected from the abdomen, and two full-thickness strips (2 ϫ 10 mm) were cut in the direction of the longitudinal or circular muscle layer from each fundal or antral gastric region. One end of each strip was tied to a platinum rod while the other was connected to a force displacement transducer (Grass model FT03) by a silk thread for continuous recording of isometric tension. The transducer was coupled to polygraph systems (Sanborn model 7700 or Grass model 7K). Muscle strips were mounted in 5-ml double-jacketed organ baths containing Krebs-Henseleit solution, gassed with 95% O2-5% CO2 mixture of the following composition (in mM): 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 2.5 CaCl2, and 10 glucose (pH 7.4). Prewarmed water (37°C) was circulated through the outer jacket of the tissue bath via a constant-temperature circulator pump. The temperature of the Krebs-Henseleit solution in the organ bath was maintained within Ϯ0.5°C.
Electrical field stimulation (EFS) was applied via two platinum wire rings (2 mm diameter, 5 mm apart) through which the preparation was threaded. Electrical impulses (rectangular waves, 80 V, 4 -16 Hz, 0.5 ms, for 15 s) were provided by a Grass model S8 stimulator. Strips were allowed to equilibrate for 1 h under an initial load of 0.8 g. During this period, repeated and prolonged washes of the preparations with Krebs-Henseleit solution were done to avoid accumulation of metabolites in the organ baths.
Experimental protocol. In a first series of experiments, the effects of obestatin on gastric fundal and antral strips were tested. The influence of the peptide on both neurally induced and direct smooth muscle contractile responses was investigated. EFS was performed at different stimulation frequencies in the absence or in the presence of the following drugs:
The interval between two subsequent electrical stimulations was determined by the time taken by strip tension to return to baseline. Methacholine (2 M) was employed to obtain direct muscular responses. The interval between two subsequent responses to methacholine was no less than 30 min, during which repeated and prolonged washes of the preparations with Krebs-Henseleit solution were performed.
To assess the viability of the preparations, in all the above sets of experiments, contractile responses to 2 M methacholine were performed and compared at the beginning and at the end of each experiment except in the strips that had been treated with atropine.
In a second set of experiments, the effects of obestatin on the neurally induced nonadrenergic, noncholinergic (NANC) relaxant responses were investigated. For this purpose, guanethidine and carbachol (CCh) were added to the bath medium to rule out the adrenergic and the cholinergic influences, respectively. When contraction elicited by CCh reached a stable plateau phase, EFS or drugs were applied. The interval between two subsequent applications of CCh was no less than 15 min, during which repeated and prolonged washes with Krebs-Henseleit solution were done.
Drugs. The following drugs were used: obestatin, guanethidine, atropine sulfate, dimethylphenyl piperazinium iodide (DMPP), L-NNA, TTX, methacholine, CCh, and nifedipine. All drugs were obtained from Sigma (St. Louis, MO) except for obestatin which was obtained from Tocris (Bioscience). Solutions were prepared on the day of the experiment, except for TTX, for which a stock solution was kept stored at Ϫ20°C. Drug concentrations are given as final bath concentrations (molar) and are in the range of those previously employed in in vitro preparations (3, 4, 6, 9, 10, 14) .
Data analysis. Amplitude of contractile responses is expressed as percentage of the muscular contraction evoked by 2 M methacholine, assumed as 100% or as absolute values (grams). Amplitude of contractile responses to methacholine was measured 30 s after a stable plateau phase was reached. Relaxant responses are expressed as percentage decrease relative to the muscular tension induced by 1 M CCh just before obtaining relaxations. Amplitude values of EFSinduced fast relaxations refer to the maximal peak obtained during the stimulation period. Amplitude values of EFS-induced sustained relaxations refer to the maximal peak, obtained following the stimulation period, with respect to the prestimulus level.
Electrophysiological experiments. The same gastric preparations as described above were used for the electrophysiological study by means of standard microelectrodes in voltage clamp at room temperature (ϳ23°C). Briefly, after the stomach was excised and cut in the longitudinal direction along the lesser curvature, smooth muscle tissues were isolated from the fundal or antral region. Under a dissecting microscope, smooth muscle tissue strips (about 6 ϫ 20 mm) were produced. One muscle strip was pinned down on a Sylgard-coated (Dow Corning, Midland, MI) recording chamber with longitudinal or circular layer up to insert a glass microelectrode and record from a longitudinal or circular smooth muscle cell, respectively. The chamber was filled with a Krebs solution having the same composition as that used in mechanical experiments, and a glass microelectrode was inserted in a smooth muscle cell. During the electrophysiological records, the tissue was superfused at a rate of 1.8 ml/min with bath solution. To record only Ca 2ϩ currents, we used a high-tetraethylammonium chloride (TEA) solution (Na ϩ and K ϩ free) (in mM): 10 CaCl2, 145 tetraethylammonium bromide, and 10 HEPES. We used nifedipine (10 M) to selectively block L-type Ca 2ϩ current (ICa,L). Heptanol (1 mM) was consistently used to block gap junctional currents and to record ionic currents elicited only from the impaled cell (12, 25) . The microelectrodes (60 -70 M⍀), pulled from borosilicate glass (GC 150 -15; Clark) by a micropipette vertical puller (Narishige PC-10), were filled with the internal solution containing (in mM): 130 KCl, 10 NaH 2PO4, 0.2 CaCl2, 1 EGTA, 5 MgATP, and 10 HEPES. The pH was adjusted to 7.4 with NaOH and to 7.2 with TEA-OH for bath and pipette solution, respectively.
Protocols of stimulations. Details of the recording technique and set up have already been published (25) . Briefly, the microelectrode was coupled to a micromanipulator (Narishige International) and an Axopatch 200B amplifier (Axon Instruments). Voltage-clamp stimulating protocols as well as data acquisition were controlled by using A/D-D/A interfaces (Digidata 1200; Axon Instruments) and Pclamp 9 software (Axon Instruments). The passive-property parameters (membrane conductance, G m, and capacitance, Cm, and Gm/Cm) were evaluated in Krebs solution in voltage-clamp mode as in Formigli et al. (11) . Taking into account that Cm (in pF) is an index of cell-surface area assuming that membrane-specific capacitance is constant at 1 F/cm 2 , the membrane current amplitudes, I (in pA), were methodically normalized to cell linear capacitance Cm to allow comparison of test currents recorded from different cells and reported normalized as I/C m (in pA/pF). To analyze Ca 2ϩ current activation, records were made in high-TEA solution, and 4-s-long voltage pulses from Ϫ70 to 50 mV were applied to voltage-clamped cells held at Ϫ80 mV in 10-mV increments. Because of the slow Ca 2ϩ current, the pulse protocol used a 20-s interval between stimulating episodes to allow recovery. The steady-state inactivation was studied by a two-pulse protocol with a 1-s prepulse to different voltages followed by a 1-s test pulse fixed to 0 mV after 200 ms. The interpulse interval to the holding potential was chosen both to avoid significant recovery from inactivation between activating pulses and to allow the activation kinetics of the Ca 2ϩ channel to come back to its resting state. Once more, in the two-pulse protocol, we used an interval of 20 s between stimulating episodes for recovery.
Data analysis. The steady-state ionic current of activation was calculated by
and the steady-state inactivation by
where Gmax represents the maximal conductance for the Ia, Vr is the apparent reversal potential, Va and Vh are the potentials eliciting the half-maximal activation and inactivation values, respectively; and ka and kh are the steepness factors. To evaluate Ca 2ϩ currents, we used the P/4 subpulse correction of cell leakage and capacitance, which also minimized the not-voltage-dependent currents (12) . Mathematical and statistical analysis of data was performed by pClamp9 (Axon Instruments).
Statistical analysis. Statistical analysis was performed by means of Student's t-test to compare two experimental groups or one-way ANOVA when more than two groups were compared. When ANOVA suggested the existence of significant differences, we performed multiple comparisons between groups by the Newman-Keuls posttest. For all statistical tests, values were considered significantly different with P Ͻ 0.05. Results are given as means Ϯ SE. The number of muscle strip preparations or investigated cells is designated by n in RESULTS.
RESULTS

Mechanical Results
In the longitudinal fundal strips at basal tension, EFS (4 -16 Hz) caused contractile responses whose amplitude increased by increasing the stimulation frequency ( Fig. 1) . EFS-induced excitatory responses were abolished by TTX (1 M) or atropine (1 M), but not influenced by guanethidine (1 M), indicating their nervous and cholinergic nature.
Addition of obestatin (0.4 M) to the bath medium (n ϭ 12) caused a decrease of the basal tension (P Ͻ 0.05) and a reduction in amplitude of the EFS-induced contractile responses in the whole range of stimulation frequency employed (Fig. 1) . The effects of obestatin were already present following 30 s-1 min from its addition to the bath medium and persisted up to 1 h (longer time not observed). In the presence of TTX (1 M), obestatin (0.4 M) still caused a decay of the basal tension, indicating a direct muscular effect (results not shown). The decay of the basal tension caused by obestatin was abolished by nifedipine (10 M).
The NO synthesis inhibitor, L-NNA (200 M), greatly increased (n ϭ 6) the amplitude of the EFS-induced contractile responses in the whole range of stimulation frequency employed (Fig. 2) . The effects of L-NNA were already present 10 min following its addition to the bath medium and persisted up to 1 h (longer time not observed). In the presence of L-NNA, obestatin (0.4 M) still caused a decay of the basal tension and 
-test).
Amplitude of contractile responses is expressed as percentage of the muscular contraction evoked by 2 M methacholine, assumed as 100%. the depression in amplitude (P Ͻ 0.05) of the EFS-induced contractile responses (Fig. 2) .
At basal tension, the addition of the ganglionic stimulating agent DMPP (10 M) to the bath medium (n ϭ 6) caused a contractile response (mean amplitude 0.75 Ϯ 0.08 g) that persisted until washout. In the presence of obestatin, the response to DMPP was reduced in amplitude (mean amplitude 0.46 Ϯ 0.06 g) (P Ͻ 0.05).
Methacholine (2 M) caused (n ϭ 8) a TTX-insensitive sustained contractile response that reached a plateau phase (mean amplitude 0.94 Ϯ 0.2 g) that persisted until washout. Obestatin (0.4 M) did not influence (P Ͼ 0.05) the response to methacholine.
The amplitude of the response to 2 M methacholine at the end of the experiments was not statistically different (P Ͼ 0.05) in all the strips tested from that obtained at the beginning, thus indicating that the viability of the preparations was not impaired.
The effects of obestatin on the longitudinal fundal strips were also tested in NANC conditions.
As previously observed (3, 4, 15) , addition of CCh (1 M) to the bath medium (n ϭ 8) caused a rapid increase in strip tension that reached a plateau phase (mean amplitude 1.32 Ϯ 0.12 g) that persisted until washout. In CCh precontracted strips and in the presence of guanethidine (1 M), EFS (4 -16 Hz) caused relaxant responses that were abolished by TTX (1 M). At the lowest stimulation frequency employed, the fast relaxation was followed, at the end of the stimulation period itself, by a rapid return of strip tension to the baseline (Fig. 3) . By increasing the stimulation frequency at or above 8 Hz, strip tension no longer suddenly returned to the initial level at the end of the stimulation period, but a further, sustained relaxant response appeared ( Fig. 3 and Table 1 ). As previously observed (3, 4) the EFS-induced fast relaxation was abolished by the NO synthesis inhibitor L-NNA (200 M).
In CCh precontracted strips, addition of obestatin (0.4 M) to the bath medium (n ϭ 6) still decreased the basal tension of the preparations without influencing the amplitude of the neurally induced fast or sustained relaxant responses in the whole range of stimulation frequency employed ( Fig. 3 and Table 1 ).
The effects of obestatin were next tested on the circular fundal strips. In these preparations, obestatin (0.4 M) had no influence (n ϭ 6) on either the basal tension or the neurally induced responses (P Ͼ 0.05).
To compare the effects of obestatin on the longitudinal fundal strips with a separate region of the stomach, experi- Values are means Ϯ SE; n ϭ 6 muscle strip preparations. Amplitude results refer to the maximal peak with respect to prestimulus level and represent percentage decreases relative to the tension induced by carbachol (CCh, 1 M). Duration is calculated from the end of the stimulation period up to the time when prestimulus level was regained. Amplitude and duration at 4 Hz are not shown because sustained relaxations were not present at this stimulation frequency. Amplitude and duration values of the electrical field stimulation (EFS)-induced sustained relaxations obtained in the presence of obestatin (0.4 M) show no significant differences compared with the control values. All P Ͼ 0.05 vs. the controls (Student's t-test) . ments on the longitudinal antral preparations were also performed.
The experiments confirm our previous observation (5): antral strips showed (n ϭ 6) an ongoing spontaneous contractile activity (mean amplitude 0.45 Ϯ 0.03 g) that was unaffected (P Ͼ 0.05) by TTX (1 M) or L-NNA (200 M). During EFS (n ϭ 6), a transient depression of the amplitude, or even the abolition, of the spontaneous motility was observed, and a contractile response (off-contraction) was often observed at the end of the stimulation period. Addition of obestatin (0.4 M) to the bath medium did not significantly influence the neurally induced responses (P Ͼ 0.05) but caused a similar decrease of the basal tension (P Ͻ 0.05) as in fundus longitudinal smooth muscle strips (results not shown).
Electrophysiological Experiments
Effects of obestatin on Ca 2ϩ currents. Modifications of Tand L-type Ca 2ϩ currents (I Ca,T and I Ca,L ) are a key event in excitation-contraction coupling in smooth muscle.
Because we observed that obestatin inhibited the mechanical response in longitudinal smooth muscle, it became essential to observe the effect of this peptide on I Ca,T and I Ca,L to evaluate if obestatin acts directly on smooth muscle. To this end, we made our current records using high-TEA solution. When a pulse protocol of stimulation for evoking Ca 2ϩ currents (see MATERIALS AND METHODS for details) was applied to longitudinal smooth muscle cells of the gastric fundus, we constantly recorded inward current traces resembling smooth muscular Ca 2ϩ currents. Representative control traces are depicted in Fig. 4A : the maximum current amplitude with a peak time, t p , of about 10 ms was observed by applying a 10-mV pulse step. The same pulse protocol was applied again 20 min after the addition of obestatin to the bath. We observed a decrease in amplitude, as well as a different voltage dependence, since the peak size was reached by a 20-mV step pulse in the presence of obestatin (Fig. 4B) . When this type of experiment was performed in the presence of nifedipine, 10 M, to block L-type Ca 2ϩ channels, we could observe a residual low voltage activated current with a rapid and transient time course (t p ϭ 6.7 ms), suggesting the involvement of I Ca,T (Fig. 4C) . The addition of obestatin decreased the maximal size of I Ca,T (30.4 Ϯ 6% of control size), slightly affecting its time to peak (6.9 ms) and negatively shifting the maximal activation from Ϫ25 to Ϫ30 mV (Fig. 5A) . By subtracting the current traces obtained in the presence of nifedipine from the total currents we obtained the L-type Ca 2ϩ channel contribution (Fig. 4E ): high-voltage-activated current traces with a slow decay were observed with the maximum amplitude reached in 14 ms by a 0-mV step pulse. Once again, the addition of obestatin decreased the size of I Ca,L (47.4 Ϯ 8%) (Figs. 4F and 5B) apparently without altering its time to peak, but shifting from 0 to 10 mV the voltage value of the pulse required to evoke the maximal current amplitude. The same effects on Ca 2ϩ currents were observed when obestatin was applied to longitudinal smooth muscle cells of the gastric antrum, as shown in a typical example reported in Fig. 6 . The related mean parameters are reported for comparison in Table 2 .
The analysis of the I-voltage (V) curve allowed us to evaluate the voltage dependence of the Ca 2ϩ currents recorded. The study was performed on I Ca,T and I Ca,L separately, in control conditions or under obestatin treatment. Any data point is the mean value Ϯ SE of the peak amplitude obtained at any voltages in all the experiments done. Figure 5 shows control I-V curves related to I Ca,T (A) and I Ca,L (B) recorded from smooth muscle cells of gastric fundus. The line through the filled symbols represents the fit of a Boltzmann function. Adding obestatin caused a strong decrease in size of all the components and a negative shift for I Ca,T and positive shift for I Ca,L . Similar results were obtained from antrum. The Boltzmann parameters for T-and L-type Ca 2ϩ found in fundus and antrum smooth muscle are reported in Table 2 . Notably, obestatin positively shifted the reversal potential of about 3 mV, suggesting a decrease of the intracellular free [Ca 2ϩ ] (Fig.  5C and Table 2 ). Finally, the steady-state activation and inactivation analysis confirmed this tendency (Table 2) . Obestatin positively shifted I Ca,T activation of 5.1 Ϯ 1 mV with respect to control, whereas it did not affect inactivation kinetics (Fig.  5D) . Obestatin positively shifted also I Ca,L , where the Boltzmann parameter representing the half-maximal activation voltage value was shifted 19.8 Ϯ 4 mV toward more positive potentials (Fig. 5E) . Moreover, it is to note that the inactivation curves did not steadily keep on at zero level at positive potentials but progressively increased causing a sort of Ushaped inactivation curve. This behavior may suggest that inactivation was Ca 2ϩ dependent. Obestatin depressed this phase, maybe because of the minor intracellular [Ca 2ϩ ], as a consequence of the decreased Ca 2ϩ influx trough L-type Ca 2ϩ channels, also confirmed by the shift of I Ca,T and I Ca,L V r toward more positive potentials (Table 2) . (Fig. 7A) . In contrast, the resting G m /C m values were decreased to a similar extent in both fundus and antrum under the obestatin addition (Fig. 7B) , suggesting a reduced permeability of the resting muscle cell membrane. Moreover, also I Ca,T and I Ca,L are greater in size in antral with respect to fundal cells, but obestatin decreased their amplitude to a similar extent (Fig. 7, C and D) . Table 2 .
Comparative effects of obestatin on passive properties and I Ca,T and I Ca
DISCUSSION
The present results indicate that, in the longitudinal gastric preparations, obestatin, other than depressing the neurally induced contractile responses in the fundal strips, directly acts on fundal and antral smooth muscles. As previously observed (5, 14) , in the present mechanical experiments, at basal tension, EFS evoked contractile responses whose abolition by TTX or atropine indicates that cholinergic nervous fibers are activated during the stimulation period.
The reduction in amplitude of the EFS-induced contractile responses by obestatin in longitudinal muscle of fundus might indicate a modulatory role exerted on the cholinergic neurotransmission. However, gastric responses are the result of a balance between nervous excitatory and inhibitory influences exerted on the smooth muscle. Because during EFS both excitatory and inhibitory nervous fibers are simultaneously activated, the decrease in amplitude of the neurally induced contractile responses caused by obestatin in the longitudinal muscle might be ascribable to either a lower activation of the excitatory component or a higher nervous inhibitory influence exerted on the smooth muscle. The main excitatory input to the gastric smooth muscle is represented by acetylcholine, whereas the inhibitory one is exerted by NANC neurotransmitters. Among them, nitric oxide is considered the main NANC neurotransmitter causing gastrointestinal relaxations (21, 23) .
In the present experiments, the observation that the NO synthesis inhibitor L-NNA increased the amplitude of the EFS-induced contractile responses suggests the removal of a nitrergic inhibitory nervous component involved in such responses. On the other hand, the possibility that the effects of obestatin on the contractile responses could be ascribable to a major nitrergic inhibitory nervous influence exerted on the smooth muscle was excluded from the observation that obestatin depressed the amplitude of the neurally induced contractile responses even in the presence of L-NNA. This is further confirmed from experiments carried out in NANC conditions. As previously observed (3, 4, 15) , in gastric strips precontracted with CCh and in the presence of guanethidine, to rule out the cholinergic and noradrenergic components, respectively, a fast relaxant response during EFS was obtained. The abolition of this response by the nitric oxide synthesis inhibitor L-NNA indicated its nitrergic nature. The lack of effects of obestatin on the neurally induced relaxant responses, other than indicating that the peptide did not influence the inhibitory neurotransmission, further suggests that the depression in amplitude of the EFS-induced contractile responses caused by obestatin is not ascribable to an increased release, by obestatin itself, of inhibitory neurotransmitters, particularly of NO, whose release occurs during the electrical stimulation of gastric preparations (15) . Therefore, from the present experiments the effects of obestatin on the fundal longitudinal muscle strips appeared to be due to an inhibitory neuromodulatory action exerted by the peptide on the cholinergic neurotransmission. Furthermore, the ability of obestatin to depress the amplitude of the response to the ganglionic stimulating agent DMPP indicates that the action of the peptide is exerted at the postganglionic level.
The neuromodulatory action of obestatin is further supported by its lack of effects on the direct smooth muscle responses elicited by methacholine. This observation also excludes aspecific effects of obestatin on the EFS-induced contractile responses. Furthermore, the similar amplitude of the response to methacholine at the beginning and at the end of the experiments demonstrated that the capacity of response of the muscle was not compromised.
In the present experiments, the lack of effects of obestatin on the circular muscle strips from the gastric fundus is in agreement with previous studies in which obestatin did not influence the neurally induced responses in the circular muscle preparations (partially or totally mucosa free) of the fundus region from rodents (6, 9, 10) . Similar results have been obtained in ghrelin knockout mice (9) .
On the other hand, the discrepancy of effects of obestatin between the two muscle layers is not so surprising, taking into account their specific features (24) but rather suggests that the peptide exerts site-specific effects. This is further supported by the observation that obestatin differently acts at the neural and/or at the smooth muscle level in relation to the gastric region considered. In this view, the ability of obestatin to cause a decay of the basal tension in the presence of TTX in both fundal and antral strips indicates that the peptide also directly acts on the smooth muscle. Thus, the results of the present study suggest that obestatin, other than depressing the neurally induced contractions at the postganglionic level in the longitudinal fundal strips, directly acts on both fundal and antral smooth muscles. Accordingly, we focused our investigation on the electrical properties of smooth muscle cells of this particular gastric region since, to our knowledge, no information exists about the actions of obestatin on the electrophysiological properties of this gastrointestinal tract.
Our results actually show new findings such as the presence of voltage-gated I Ca,T in longitudinal smooth muscle of stomach fundal and antral regions of mouse, hardly ever observed Another new finding is the behavior of I Ca,L that did not completely inactivate, since its decay reached a steady-state different from zero, and, in addition, it showed a U-shaped inactivation curve as observed in duodenal longitudinal smooth muscle of mouse (25) . The consequence is that smooth muscle of stomach fundal and antral regions could retain a long-lasting depolarized state useful for maintaining a long-lasting contractile state and small contractile rate functional for stomach segmental contraction and that obestatin impaired such properties since it depressed the U-shaped inactivation.
Moreover, obestatin decreases the resting G m /C m value denoting a reduced permeability of the resting muscle cell membrane and consequently less susceptibility to passive ionic inand out-ionic fluxes.
Finally, results obtained from the electrophysiological experiments indicate that the direct action of obestatin on gastric fundus and antrum smooth muscles appears ascribable, at least in part, to the ability of the peptide to cause inhibition of I Ca,T and I Ca,L size, which was of about 3.4-and 2.8-fold, respectively, and to positively shift their voltage threshold of activation of 5 and 8 mV, and V a values of 8 and 18 mV. Such inhibition of Ca 2ϩ currents and the positive shift of V r of about 4.3 and 3.8 mV suggest a lesser intracellular free [Ca 2ϩ ] that may explain the decrease of the basal tension observed in the mechanical experiments. Because of the comparable results obtained in antrum and fundus, we can reasonably suggest that the direct action of obestatin on longitudinal gastric smooth muscle cells involves a similar mechanism.
The possibility that the depressant effects of obestatin on the neurally induced contractile responses observed in the longitudinal fundal strips may be ascribable to its direct effects on the smooth muscle can be excluded by the observation that the EFS-induced relaxant responses are not influenced by the peptide. On the other hand, the lack of effects of obestatin on the response to methacholine, notwithstanding its influence on Ca 2ϩ currents, might be ascribable to a "massive" direct activation of the pathways involved in the contractile response elicited by the muscular muscarinic receptor agonist.
In conclusion, the present data indicate that obestatin, other than acting at the postganglionic level by modulating the cholinergic neurotransmission in the longitudinal fundal strips, directly influences in both fundal and antral preparations the longitudinal smooth muscle activity.
These inhibitory effects of obestatin could support and at least partly justify the suggested occurrence of opposite actions exerted by ghrelin on gastric motility and thus on feeding behavior (1, 10, 22, 26) . In any case, because of complex relation of smooth muscle electrical properties, contractility and phenotypic function of gastric accommodation, emptying, and overall satiety, we should use prudence in suggesting such correlations from an in vitro study. Actually, from a physiological point of view, the decay of the basal tension caused by obestatin might contribute undeniably to the distension of the gastric wall. This event is commonly supposed to be one of the major signals involved in the regulation of food intake.
A better understanding of the role of obestatin in gastrointestinal motility and in the complex balance of energy homeostasis may be fundamental to define its action as an anorectic hormone able to decrease food intake and, consequently, for the potential treatment of obesity. 
